DIAJARD MXR 25/1000MG TABLET

Diajard MXR 25/1000mg tablet is a combination medication that contains two active ingredients: Empagliflozin and Metformin. It is used in the management of type 2 diabetes mellitus. Empagliflozin belongs to the class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, while Metformin is a biguanide medication. Diajard MXR tablets are formulated to help control blood sugar levels in individuals with type 2 diabetes.

Uses:

1. Type 2 Diabetes Management: Diajard MXR 25/1000mg tablet is used to help control blood sugar levels in adults with type 2 diabetes. It is typically prescribed when diet and exercise alone are not sufficient to manage blood glucose levels. Empagliflozin works by blocking the reabsorption of glucose by the kidneys, causing the body to excrete excess glucose through urine. Metformin helps reduce glucose production by the liver and improves insulin sensitivity.

Side Effects:

Diajard MXR 25/1000mg tablet is generally well-tolerated when used as directed. However, some individuals may experience certain side effects. Common side effects of Diajard MXR tablets may include:

1. Urinary Tract Infections: Empagliflozin may increase the risk of urinary tract infections in some individuals.
2. Genital Infections: Empagliflozin may also increase the risk of genital yeast infections in some individuals.
3. Gastrointestinal Disturbances: Metformin can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, or abdominal discomfort.
4. Hypoglycemia: When used alone or in combination with certain other antidiabetic medications, Diajard MXR tablets may increase the risk of low blood sugar levels (hypoglycemia). This is more likely to occur when combined with insulin or sulfonylureas.

When Not to Use:

There are certain situations when Diajard MXR 25/1000mg tablet should not be used. These include:

1. Type 1 Diabetes: Diajard MXR tablets are specifically indicated for the management of type 2 diabetes and should not be used in individuals with type 1 diabetes.
2. Diabetic Ketoacidosis: Diajard MXR tablets should not be used in individuals with diabetic ketoacidosis, a severe complication of diabetes characterized by high blood sugar levels and the presence of ketones in the blood or urine.
3. Severe Kidney or Liver Disease: Diajard MXR tablets should be used with caution or avoided in individuals with severe kidney or liver disease, as they may affect kidney function or worsen liver conditions.

It is important to consult a healthcare professional or refer to the product’s packaging and accompanying instructions for specific guidance on using Diajard MXR 25/1000mg tablets, including dosage, duration of use, and potential interactions with other medications. Regular monitoring of blood glucose levels is recommended during treatment with Diajard MXR tablets.